MAPK1 and systemic sclerosis: Inhibition of NADPH oxidase with DPI or treatment with NAC in SSc T cells determined a reduction of activated ERK1/2 levels, demonstrating an important role for ROS in the upstream activation signaling of MEK/ERK in SSc T cells.